The medical profession, in which veterinary pharmaceuticals play an important part, has seen considerable developments as drug developers attempt to improve the overall efficacy of their products. Other aspects that have received attention during the pharmaceutical development phase include cost-effectiveness, ease of administration, and suitability for mass immunisation.
The veterinary therapeutics market in Saudi Arabia is likely to be driven by the rising prevalence of chronic illnesses in pets. Increasing innovations and research and development activities in veterinary pharmaceuticals are driving the Saudi Arabia veterinary therapeutics market. Drug development is a constant priority for players, who assess the entire effectiveness of their products. Rising consumer awareness, product cost-efficiency, and simple availability are just a few of the factors driving the market's rapid growth. The Saudi Arabian government's measures to assist the agriculture industry are propelling the worldwide market.
In veterinary pharmaceuticals, there's been an upsurge in demand for high-quality proteins. The development in livestock medications is due to an increase in demand for animal proteins, as well as increased nutrition awareness and food safety. The oral administration of veterinary medications, antibiotics, and amino acids, as well as feed additives, is becoming more common. The field of veterinary drugs is constantly expanding, as it plays an important part in the medical industry. Manufacturers are being encouraged to develop technologically powerful and highly efficient products as the Saudi Arabian government increases its support for agricultural activities.
In Saudi Arabia, veterinary pharmaceutical industry participants are projected to see increased prospects to break into the market. In the next few years, the government's various measures to support private companies in the veterinary therapeutics industry is projected to increase business. The Saudi Arabian government supports the agriculture business by providing technical assistance, interest-free loans, long-term, incentives, free seeds and fertilisers, and low-cost water, fuel, and power. Farmers are also allowed duty-free imports of raw materials and machinery to help them enhance productivity. The government is providing subsidies for the export of corn, which is commonly used in chicken feed.
Saudi Arabia's increased demand for veterinary medications, vaccinations, and medicated feed additives is likely to boost the global market. The increased demand for anti-infectives, anti-inflammatory medications, and parasiticides is providing chances for market participants. These medications are used to keep cattle healthy. The utilization of companion animals is at an all-time high. Companion animal ownership is predicted to increase in the near future, which would likely drive the Saudi Arabian veterinary pharmaceutical market.. Due to the increased prevalence of zoonotic illnesses, vaccines are also in great demand.
Saudi Arabia Veterinary Pharmaceuticals market Segment
Based on the type Injectable, Oral, Topical and Auricular, Ophthalmic, And Nasal. Due to growing concerns about animal health, injectables are likely to dominate the market. As disease-prevention medicines evolve, the development of injectables for animals is driving the market growth. Due to a growth in the number of animal diseases, the pharmaceuticals business is predicted to grow dramatically. Chronic disorders like as cancer and haemorrhoids are becoming more common in older animals, resulting in higher demand for the best-suited treatments and, as a result, helping the Saudi Arabia veterinary pharmaceutical market's growth.
Based on the animal type, the market is divided into two categories producing animals and companion animals. Foods such as chicken, sheep and goats, cattle, and others are supported by production animals. Dogs, cats, horses, and other companion animals are examples of companion animals. On the basis of animal food items such as milk and dairy goods, chicken products, and so on, production animals dominate the market. The Saudi Arabian veterinary pharmaceutical sector is predicted to grow in the next five years as demand for protein-rich food products generated from poultry or fish grows.
Based on the end-user, the market is divided into vet hospitals and clinics, animal farms and others. During the forecast period, due to an increase and improve services in the number of veterinary hospitals and clinics in Saudi Arabia. The surge in pet ownership is driving the veterinary treatments business in the country as a result the need for veterinary clinics has also increased. Furthermore, an increase in the number of veterinary pharmacies is predicted to enhance the industry. Moreover, increased sales of over-the-counter veterinary medications and other pharmaceutical items are expected to provide attractive prospects for market participants. The number of companies active in the Saudi Arabian veterinary pharmaceuticals industry is steadily expanding.
The high cost of veterinary healthcare services and the lack of pet insurance are the two key factors limiting the market's growth. Veterinary treatment for domestic pets is expensive in Saudi Arabia, and it can be more expensive than human medical care. Vaccinations, doctor appointments, medication, and supplies for a dog are all highly expensive in Saudi Arabia. If the animals are diagnosed with ailments, the total cost is expected to grow. Moreover, due to a lack of inexpensive pet insurance, pet owners leave their animals.
Impact of COVID-19
The livestock industry has been greatly impacted by COVID-19. Travel restrictions, statewide lockdowns, and border controls implemented in several nations throughout the world to stem the spread of the coronavirus have resulted in the following outcomes: difficulty moving live animals and animal products such as milk, meat, and eggs, seasonal border crossing restrictions and constraints with ruminants, limited capacity to acquire critical production inputs and limited access to labour and professional services.
The Saudi Arabia veterinary pharmaceuticals market is moderately segmented, with a number of multinational and domestic companies competing. The market is very competitive due to the vast number of small and medium-sized businesses. The market's high development potential is bringing new local and international companies to the market. The following companies are major players in the worldwide Saudi Arabia Veterinary market: Montajat Company, Vetoquinol India Animal Health Pvt Ltd.., Saudi Pharmaceutical, Industries SPI, Pharma Care Leading Manufacturing Co. Ltd., Salehiya, Merck & Co., Inc.
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Function
4.4. Function Value Chain Analysis
5. Saudi Arabia Veterinary Pharmaceuticals Market, By Type
5.5. Auricular, Ophthalmic, And Nasal
6. Saudi Arabia Veterinary Pharmaceuticals Market, By Animal Type
6.2. Companion Animal
6.3. Production Animal
7. Saudi Arabia Veterinary Pharmaceuticals Market, By End-Use
7.2. Vet Hospitals and Clinics
7.3. Animal Farms
8. Competitive Environment and Analysis
8.1. Emerging Players and Market Lucrativeness
8.2. Mergers, Acquisitions, Agreements, and Collaborations
8.3. Vendor Competitiveness Matrix
9. Company Profiles.
9.1. Montajat Company
9.2. Vetoquinol India Animal Health Pvt Ltd.
9.3. Saudi Pharmaceutical Industries SPI
9.4. Pharma Care Leading Manufacturing Co. Ltd.
9.6. Merck & Co., Inc
9.7. Major Players and Strategy Analysis
Vetoquinol India Animal Health Pvt Ltd.
Saudi Pharmaceutical Industries SPI
Pharma Care Leading Manufacturing Co. Ltd.
Merck & Co., Inc
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.